Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The point-of-care (POC) HbA1c testing market has witnessed significant expansion recently, driven by the urgent need for efficient diabetes management tools. With rising diabetes cases worldwide, the demand for quick, reliable, and accessible HbA1c testing methods is growing rapidly. Let’s explore the market’s size, key growth drivers, leading companies, emerging trends, and regional dynamics shaping this industry’s future.

Steady Growth and Market Size Outlook in the POC HbA1c Testing Market

The POC HbA1c testing market has experienced rapid growth in recent years, with its value expected to rise from $1.02 billion in 2025 to $1.14 billion in 2026, reflecting an impressive compound annual growth rate (CAGR) of 11.9%. This historic growth is largely due to the increasing global prevalence of diabetes, the expanding reliance on long-term glucose monitoring in clinical settings, broader availability of outpatient diagnostic services, heightened awareness about early diabetes detection, and the accessibility of compact diagnostic tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp

Looking ahead, the market is projected to reach $1.76 billion by 2030, maintaining a strong CAGR of 11.4% during the forecast period. Growth factors fueling this surge include wider adoption of decentralized diagnostic testing, rising consumer preference for home-based care solutions, the expansion of digital diabetes management programs, a stronger emphasis on preventive healthcare, and increased investments in rapid diagnostic technology. Key market trends include the growing use of rapid point-of-care HbA1c devices, portable and handheld testing systems, home monitoring, integrated POC diagnostic platforms, and a focus on enhancing test accuracy and standardization.

Primary Factors Propelling Demand in the POC HbA1c Testing Market

The escalating number of diabetes cases worldwide is a fundamental driver for the POC HbA1c testing market’s expansion. Diabetes, a chronic metabolic disorder marked by elevated blood sugar levels, demands consistent monitoring to prevent serious health complications such as nerve damage, cardiovascular issues, and kidney disease. Lifestyle factors including sedentary habits, poor diet, obesity, and aging populations globally contribute to the rising incidence of diabetes.

Access The Complete Poc Hba1C Testing Market Report:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

This increasing diabetic population is boosting the need for quick and reliable tests that enable effective glycemic control across clinical settings, pharmacies, and home care environments. For example, according to the International Diabetes Federation in 2025, approximately 589 million adults aged 20 to 79 were living with diabetes, with projections estimating that this number will grow to 853 million by 2050. Notably, over 80% of adults with diabetes reside in low- and middle-income countries, highlighting the critical role of accessible POC HbA1c testing solutions in managing this health challenge.

Product and Technology Segments Defining the POC HbA1c Testing Market

This market is divided into several key segments by product type, technology, and end user. Products include instruments and consumables. Instruments further encompass handheld HbA1c testing devices, portable analyzers, desktop testing systems, and integrated point-of-care testing systems. Consumables include test strips, control solutions, reagents, calibration solutions, and sample collection devices.

Technological classifications cover ion-exchange high-performance liquid chromatography (HPLC), enzymatic assays, affinity binding chromatography, immunoassay, and other emerging methods. The end users of these products span hospitals, physician offices or outpatient centers, home care settings, and various other clinical environments.

Innovations and Trends Shaping the Future of POC HbA1c Testing

Leading companies are increasingly embedding built-in internal verification systems into their devices to enhance test accuracy, minimize errors, and build confidence in near-patient diagnostics. These automated self-check features monitor environmental conditions, sample quality, and assay performance throughout testing to prevent faulty outcomes or sample loss.

For instance, in July 2024, Siemens Healthineers introduced the next-generation Atellica DCA Analyzer. This device uses proprietary Auto-Checks Technology, conducting continuous internal calibrations and environmental checks including airflow, temperature, sample volume, optical clarity, and precision during each test. Such automation delivers lab-quality HbA1c results within 4 to 5 minutes, reduces operator oversight needs, minimizes pre-analytical errors, and supports expansion of point-of-care testing especially in areas with limited laboratory infrastructure.

Key Market Players Competing in the POC HbA1c Testing Industry

The POC HbA1c testing market features numerous prominent companies competing globally. Leading players include F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, and Bionime Corporation.

Geographical Insights and Regional Market Leadership in POC HbA1c Testing

In 2025, North America held the largest share of the POC HbA1c testing market, benefiting from advanced healthcare infrastructure and strong diabetes management programs. However, Africa is expected to be the fastest-growing region during the forecast period, driven by increasing healthcare investments, growing awareness, and expanding diagnostic capabilities. The market analysis also includes other important regions such as Asia-Pacific, South East Asia, Western and Eastern Europe, South America, and the Middle East, providing a comprehensive view of global market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model